ClinicalTrials.Veeva

Menu

Whey Protein Supplementation and Serum Mineral Status in Elite Endurance and Power Athletes

M

Monira Aldhahi

Status

Completed

Conditions

Athletic Performance

Treatments

Other: No Supplement (Control)
Dietary Supplement: Whey Protein Supplementation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study investigates whether 8 weeks of post-training whey protein supplementation (30 g/day) affects serum mineral concentrations (calcium, phosphorus, magnesium, and iron) in elite endurance and power athletes during structured training.

Full description

This is a 10-week non-randomized, open-label intervention study involving elite male track-and-field athletes aged 18-26 years. Participants are allocated into a whey protein supplementation group or a control group based on convenience allocation. The intervention consists of daily intake of 30 g whey protein following training sessions over 8 weeks. Blood samples are collected at baseline and post-intervention to assess serum calcium, phosphorus, magnesium, and iron levels. The study aims to differentiate supplementation effects from training-induced physiological changes.

Enrollment

59 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male elite track-and-field athletes
  • Age 18-30 years
  • Engaged in structured training program
  • No supplement use in past 3 months

Exclusion criteria

  • Use of nutritional or mineral supplements
  • Metabolic or musculoskeletal disorders
  • Acute injury affecting performance
  • Use of ergogenic aids (e.g., creatine, anabolic agents)

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

59 participants in 2 patient groups

Whey Protein Group (WG)
Experimental group
Description:
Receives 30 g/day whey protein post-training for 8 weeks
Treatment:
Dietary Supplement: Whey Protein Supplementation
Control Group (CG)
Other group
Description:
Continues usual training without supplementation
Treatment:
Other: No Supplement (Control)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems